Hematocrit Test Devices Market Poised to Hit $6.19 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Hematocrit Test Devices Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for hematocrit test devices has seen robust growth. The market is projected to expand from $4.63 billion in 2024 to $4.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.0%. The market growth during the historic period can be associated with factors such as increased consciousness about anemia, iron and vitamin deficiencies, a rise in chronic disease incidence, soaring government funding, and population growth.

How Will the Hematocrit Test Devices Market Size Evolve and Grow by 2029?
The market size for hematocrit test devices is anticipated to witness significant expansion in the coming years, soaring up to $6.19 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. The upswing through the prediction period is credited to factors like a rising trend of anemia, escalating occurrences of blood disorders, increase in elderly population, heightened emphasis on health and fitness, and an expanding demand for cardiovascular diagnostic tools. Noteworthy trends during the forecast timeline encompass the launch of avant-garde solutions, rapid progress in medical technology, emergence of new efficient and innovative products, technological strides in hematocrit testing, and advancements in the healthcare industry.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

What Drivers Are Propelling the Growth of Hematocrit Test Devices Market Forward?
The hematocrit test devices market is projected to expand as a result of rising instances of blood disorders. Blood disorders, which impact various components of human blood like red and white blood cells, platelets, and blood plasma, are becoming increasingly prevalent due to a combination of factors such as genetic predisposition, environmental pollution, and changes in lifestyle. Hematocrit test devices, which quantitatively assess the volume percentage of red blood cells in total blood, provide vital data about a patient's hematological health status. For example, a report released by the American Cancer Society, a US-based non-profit organization, in January 2024 predicts that around 62,770 new leukemia cases of all varieties will emerge in the United States in 2024, resulting in roughly 23,670 fatalities. Of these, nearly 20,800 will be new cases of acute myeloid leukemia (AML), predominantly in adults, with an estimated 11,220 AML-related fatalities, predominantly among adult patients. As a consequence, the upward trend of blood disorders is boosting the hematocrit test devices market growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

What Are the Key Trends Driving Hematocrit Test Devices Market Growth?
Key players in the hematocrit test device market are making strides in product innovation, specifically in the development of complete blood count (CBC) hematology analyzers that can provide both qualitative and quantitative data about various blood cells. These automated instruments can evaluate and measure different components of blood such as white blood cells (WBCs), red blood cells (RBCs), and platelets. A confirmation of this is Mindray Medical International Limited, a Chinese medical device firm, that introduced the BC-700 hematology analyzer series in March 2022. This series, which includes the BC-720, BC-760, and BC-780, integrates complete blood count (CBC) tests and erythrocyte sedimentation rate (ESR) tests. Designed to equip medium-volume labs with advanced diagnostic technologies akin to high-end products, the BC-700 Series is a smaller variant of the premium BC-6000 Series and features Mindray's unique SF Cube 3D analysis tech. This technology employs fluorescence and bi-angular laser scatter signals to examine target cells in a three-dimensional context.

What Are the Key Segments in the Hematocrit Test Devices Market?
The hematocrit test devices market covered in this report is segmented -

1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables
2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications
3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users

Subsegments:
1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters
2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers
3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15582&type=smp

Who Are the Key Players Shaping the Hematocrit Test Devices Market's Competitive Landscape?
Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

What Geographic Markets Are Powering Growth in the Hematocrit Test Devices Market?
North America was the largest region in the hematocrit test devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15582

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.